Latest News and Press Releases

BELLEVUE, Wash., July 14, 2025 (GLOBE NEWSWIRE) -- A groundbreaking study published today in Pediatrics Open Science shows a notable increase in the use of medication to treat pediatric obesity in...

BELLEVUE, Wash., May 08, 2025 (GLOBE NEWSWIRE) -- Today, Truveta announced a new era in cancer research with more than 7 million oncology patient journeys spanning more than 100 cancer types,...

BELLEVUE, Wash., March 26, 2025 (GLOBE NEWSWIRE) -- Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare...

BELLEVUE, Wash., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Today, Truveta announced the expansion of Truveta Data with the addition of new commercial, Medicare, and Medicaid closed claims on more than 200...

BELLEVUE, Wash., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Truveta announced that its platform Truveta Studio and Truveta Data have earned certified status by HITRUST for information security. This...

BELLEVUE, Wash., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health record (EHR) data, now includes more than 120...

BELLEVUE, Wash., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced its latest AI innovation – Truveta Tru, Truveta Studio’s research assistant powered by generative AI. Trained on the...

BELLEVUE and SEATTLE, Wash., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has...

BELLEVUE, Wash., July 08, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced that its comparative effectiveness study exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...

BELLEVUE, Wash., June 18, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the Food and Drug...